Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension.
Saved in:
| Title: | Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension. |
|---|---|
| Authors: | Bowlus CL; Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, California, USA., Nevens F; Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Leuven, Belgium., Kowdley KV; Liver Institute Northwest and Elon S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA., Bonder A; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Capozza T; Intercept Pharmaceuticals Inc., Morristown, New Jersey, USA., Li J; Intercept Pharmaceuticals Inc., Morristown, New Jersey, USA., Nair R; Intercept Pharmaceuticals Inc., Morristown, New Jersey, USA., Trauner M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Jones DE; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
